Posted on 09/01/2022 12:29:09 PM PDT by lightman
COVID-19 vaccine effectiveness for all age groups has been much worse against the Omicron virus variants than earlier strains, particularly the currently dominant subvariants, according to U.S. Centers for Disease Control and Prevention (CDC) data presented on Sept. 1.
The data, much of which has never been published before, shows that the protection against both symptomatic infection and severe disease is not as strong against the Omicron, which emerged in December 2021, and its subvariants.
Data from the CDC’s Increasing Community Access to Testing, a no-cost testing program, showed that vaccine effectiveness for a booster compared to a primary series against symptomatic infection waned rapidly across all age groups, going under 50 percent within two months and turning negative around six months.
A fourth dose, or second booster, upped the protection, but the shielding quickly dropped to under 40 percent, according to estimates for those 50 and older.
Estimates drawn from the CDC’s VISION Network showed that emergency department and urgent care visits rose over time for the vaccinated, with adjusted vaccine effectiveness estimates for 5- to 11-year-olds dropping from just 51 percent 14–59 days after a primary series to 18 percent 150 days or more after the second shot.
For 12- to 15-year-olds, effectiveness went from 60 percent to just 14 percent over the same time period since vaccination.
The patterns show the vaccine effectiveness was “waning substantially,” said CDC scientist Ruth Link-Gelles while she presented the data to the agency’s vaccine advisory panel.
Data from another system, Cosmos, estimated vaccine effectiveness against emergency department and urgent care visits among 5- to 11-year-olds at 48 percent after a second dose, with the protection dropping to 11 percent but being increased to 52 percent with a booster.
Children aged 12 to 15 had better protection at first, 65 percent, but the shielding went down to 21 percent after 120 or more days. A booster restored some of the protection, but 120 or more days after the booster, protection was down to 18 percent.
Protection Worse Against Hospitalization in Recent Months
During recent months, two Omicron subvariants, BA.4 and BA.5, have increasingly displaced other virus strains.
Data drawn from those months indicate the vaccine-bestowed protection was worse during that time.
Adults designated as immunocompetent—a population reached by excluding immunocompromised—had just 44 percent protection against emergency department and urgent care visits during the period when BA.4 and BA.5 were dominant, according to the data from VISION. That time period started in mid-June.
The protection dropped to 26 percent after 150 or more days.
A booster shot increased the shielding to 59 percent but the protection waned to 33 percent after 120 or more days. Estimates for a second booster were not conclusive because of limited followup, according to Link-Gelles.
Protection against hospitalization also went down during the BA.4/Ba.5 period, according to data from VISION. Immunocompetent adults had just 25 percent protection against hospitalization 150 or more days after a second dose, and a booster only increased that to 49 percent. Moreover, those who received a booster 120 or more days earlier had just 34 percent protection.
A fourth dose increased protection to 60 percent and that protection waned more slowly, according to preliminary estimates.
Other data from the CDC’s Influenza Vaccine Effectiveness in the Critically Ill network, pegged vaccine effectiveness against hospitalization among immunocompetent adults at 62 percent from a primary series, but just 33 percent after 150 or more days.
A booster upped protection to 77 percent, but that eroded to 36 percent after 120 or more days.
A fourth dose moved protection to 62 percent seven to 120 days after the second booster for adults 50 and older.
Estimates for immunocompromised adults were only available for three doses, or a primary series and a booster. They estimated the effectiveness at 66 percent after a third shot. The shielding was down to 37 percent after over 120 days.
Updated boosters were authorized by the U.S. Food and Drug Administration this week. Regulators said the boosters, which target BA.4 and BA.5, will replace the boosters that had been in circulation since 2021.
The law of decreasing marginal utility appears to be at work.
Well, there are the new bivalent vaccines, which are being approved largely on data from mice. /S
boosters!
boosters!
git yer boosters here!
take yer chances and win, well, nuttin’
but its free
carny barker
Hard to see how it can be any less effective. EUA CONvid vax ratings are as low as branDUHn’s approval ratings.
How come so many people who have succumbed to the government sponsored jab juic come down with Covid? I thought vaccines were supposed to make people IMMUNE. Sorta like polio and small pox vaccines.
My neighbor gets his shot every six months and he’s had Covid twice. He’s just a slow learner, I guess. I told him he should just get a string of worry-beads and be done with it.
Ha ha ha. As if its effectiveness ever existed.
“....symptomatic infection and severe disease is not as strong against the Omicron....”
Ramping up the sales pitch for the “New and improved MrNA vaccine”...
I have come to the conclusion that the more jabs you have the more it fogs your brain. At my work, almost everyone has had two doses and at least one booster——they all had covid (Some once and others twice). Yet, they are counting the days on the calendar for their next shot.....Ummmmm....Ummmmmm....I got nothing other than “NUTS”!
World’s largest medical experiment.
Ping
8 mice.
Literally.
It never worked in the first place
Not!!
Not to mention lowered immunity, overall…and, worse. 😢
Schitt Don’t Work!!! glad I didn’t get the jab. and FJB!
The vaccines are suppose to be 100% safe but Pfizer committed fraud and murder with the gov’t help as you can see from the article.
Documents leaked from the EMA confirms why we aren’t allowed to analyze the vaccine vials
It’s like rolling the dice for what you get in your vial. Both the FDA and EMA knew this but kept this out of the public view because if it were known, nobody would take the vaccines.
On Nov 23, 2020, EMA knew about the quality control issues with severely compromised mRNA integrity (ranging from 78% to 55%). [It’s supposed to be 100% if you want an effective vaccine.]
Pfizer never told the public or governments about the risks associated with mRNA integrity. If it wasn’t for the leak, we’d never have known. But it’s all OK because the drug companies are exempt from any liability. The patient takes all the risk here, not the drug companies.
https://ussanews.com/2022/08/31/documents-leaked-from-the-ema-confirms-why-we-arent-allowed-to-analyze-the-vaccine-vials/
8 mice? That’s not statistically significant, not even for mice!
The 27th shot should fix everything
💉💉💉💉💉💉💉💉💉
💉💉💉💉💉💉💉💉💉
💉💉💉💉💉💉💉💉💉
My observations were it never worked. So many people I knew had ‘break through’ infections during delta (with moderater to severe disease) -omicron is just off the charts as the vaxxed appear to get it easier. Clearly nothing disclosed by the government has been truthful with this plague.
“Well, there are the new bivalent vaccines, which are being approved largely on data from mice.”
and the CDC only released the data regarding the ineffectiveness of the original experimental gene therapy to “prove” the necessity of trying to force everyone to be injected with a whole NEW series of experimental gene therapy jabs that were “approved” with almost zero testing on humans ...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.